INHIBITOR FOR HMG-COA REDUCTASE IN PREVENTION OF RESTENOSIS AFTER CORONARY BLOOD VESSEL FORMATION

摘要

PURPOSE: To prevent endothelial hyperplasia at an angioplastic site and reduce the clinical or angiographic evidence of restenosis. CONSTITUTION: A method comprises administering an HMG-CoA reductase at a dose for actively lowering whole cholesterol and LDL cholesterol to a coronary artery stenosis patient planned to receive a percutaneous transluminal coronary angioplasty(PTCA) for several days before the treatment and over a long period after the treatment.